approved EB-1A

VP

Biomedical Sciences · United Kingdom · 2025-12-09

Processing Time
20 days
Decision Date
2025-12-09
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Framework Evaluation

3 of 3 criteria met
Scholarly Articles (Met)

The petitioner authored 8 journal articles and 1 conference article in the field of biomedical sciences.

Judging (Met)

The petitioner completed at least 15 peer reviews for selective international venues in AI and computational research.

Original Contributions (Met)

The petitioner's work on antibody loop structures has garnered 904 citations and is utilized in developing next-generation therapeutics.

Why This Petition Was Approved

The petition was approved based on the satisfaction of at least three EB-1A criteria, including scholarly articles, judging, and original contributions of major significance. Specific metrics included 8 peer-reviewed journal articles, 904 citations, and 15 peer review assignments for influential AI and computational venues. The case was strengthened by evidence of competitive funding from the Bill & Melinda Gates Foundation and Roche GmbH.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Conference Presentations
Judging Experience
Original Contributions
Evidence Submitted
  • 8 peer-reviewed journal articles
  • 1 peer-reviewed conference article
  • 1 preprint
  • 904 citations reflecting global impact
  • Served as peer reviewer at least 15 times for international venues in AI and computational research
  • Pioneering contributions to machine-learning-driven drug discovery
  • Advancements in antibody loop structures for targeted antibody therapeutics

Similar Cases

Research Scientist

Artificial Intelligence · China

WeGreened EB-1A approved
Maryland 207 days 2025-10-14
The petition was approved based on 11 peer-reviewed articles and 2 preprints with 236 citations, placing several papers in the top 10% of the field. The petitioner satisfied EB-1A criteria through 11 peer reviews for leading journals, serving as an area chair for an international AI conference, and participating in federal grant reviews. His work on AI transparency and reliability was also recognized for its alignment with U.S. government regulatory initiatives.

Principal

Biotechnology · India

WeGreened EB-1A approved
California 123 days 2025-07-23
The case was approved based on 5 peer-reviewed journal articles in high-impact venues like Nature, Cell, and Science, which amassed 1,359 citations from researchers in over 50 countries. The petitioner also demonstrated significant judging experience with 13 peer reviews and an editorial board position. These metrics satisfied the criteria for original contributions of major significance, scholarly authorship, and judging the work of others.

Scientist

Pharmaceuticals · China

WeGreened EB-1A approved
Massachusetts 21 days 2025-05-29
The petition was approved based on the satisfaction of at least three EB-1A criteria: authorship of scholarly articles, participation as a judge of the work of others, and original scientific contributions of major significance. Specific metrics included 8 peer-reviewed publications in elite journals like Nature Microbiology, 260 citations placing him in the top 1% of his field, and the completion of over 20 peer reviews for high-impact journals.

Chief Executive Officer (CEO)

Biotechnology · India

WeGreened EB-1A approved
California 7 days 2025-12-01
The petition was approved based on 21 peer-reviewed journal articles and 2,148 citations, which placed the petitioner in the top 1% of highly cited authors. Additionally, the applicant provided evidence of 36 peer reviews for prestigious journals and a granted patent. The case satisfied EB-1A criteria through scholarly articles, original contributions of major significance, and a leading/critical role in a distinguished organization.

Frequently Asked Questions

A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-12-09.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 20 days
Criteria Met 3 / 3
Evidence Types 7

EB-1A Case Data

Scraped Case Data

Total Cases 881
Success Rate 52.9%
Sustained 466
Dismissed 299

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist